Nishikawa T, Omura M, Saito J, Matsuzawa Y. The possibility of resistant hypertension during the treatment of hypertensive patients. Hypertens Res. 2013;36:924–9.

Article  PubMed  Google Scholar 

Esler MD. Sympathetic nervous system moves toward center stage in cardiovascular medicine. Hypertension. 2014;63:e25–e32.

Article  PubMed  Google Scholar 

Grassi G, Bombelli M, Buzzi S, Volpe M, Brambilla M. Neuroadrenergic disarray in pseudo-resistant and resistant hypertension. Hypertens Res. 2014;37:479–83.

Article  CAS  PubMed  Google Scholar 

Dudenbostel T, Acelajado MC, Pisoni R, Li P, Oparil S, Calhoun D. Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure. Hypertension. 2015;66:126–33.

Article  CAS  PubMed  Google Scholar 

Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res. 2015;116:976–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dell’Oro R, Quarti-Trevano F, Seravalle G, Bertoli S, Airoldi F, Mancia G, et al. Sympathetic nerve traffic and arterial baroreflex function in apparent drug-resistant hypertension. Hypertension. 2019;74:903–9.

Article  PubMed  Google Scholar 

Mancia G, Mark AL. Arterial baroreflexes in humans. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology, Section 2: The cardiovascular system. Bethesda, Md: American Physiological Society; 1983. pp. 755–93.

Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011;58:765–73.

Article  PubMed  Google Scholar 

Spiering, Williams W, Heyden B, der JV, Kleef, van M, Lo R, Versmissen J, et al. Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study. Lancet. 2017;390:2655–61.

Article  PubMed  Google Scholar 

Wallbach M, Lehning LY, Schroer C, Luders S, Bohning E, Muller GA, et al. Effects of baroreflex activation therapy on ambulatory blood pressure in patients with resistant hypertension. Hypertension. 2016;67:701–9.

Article  CAS  PubMed  Google Scholar 

Wallback M, Koziolek MJ. Baroreceptors in the carotid and hypertension – systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressure. Nephrol Dial Transpl. 2019;33:1485–93.

Google Scholar 

Lohmeier TE, Irwin ED, Rossing MA, Serdar DJ, Kieval RS. Stimulation of the baroreflex produces sustained hypotension. Hypertension. 2004;43:306–11.

Article  CAS  PubMed  Google Scholar 

Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension. 2009;54:690–97.

Article  CAS  PubMed  Google Scholar 

Page MJ, Moher D. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement and extensions: a scoping review. Syst Rev. 2017;6:263.

Article  PubMed  PubMed Central  Google Scholar 

Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension. 2010;55:619–26.

Article  CAS  PubMed  Google Scholar 

Heusser K, Tank J, Brinkmann J, Menne J, Kaufeld J, Linnenweber-Held S, et al. Acute response to unilateral unipolar electrical carotid sinus stimulation in patients with resistant arterial hypertension. Hypertension. 2016;67:585–91.

Article  CAS  PubMed  Google Scholar 

Heusser K, Thöne A, Lipp A, Menne J, Beige J, Reuter H, et al. Efficacy of electrical baroreflex activation is independent of peripheral chemoreceptor modulation. Hypertension. 2020;75:257–64.

Article  CAS  PubMed  Google Scholar 

Van Kleef MEAM, Heusser K, Diedrich A, Oey PL, Tank J, Jordan J, et al. Endovascular baroreflex amplification and the effect on sympathetic nerve activity in patients with resistant hypertension. A proof-of-principle study. PloS One. 2021;16:e0259826.

Article  PubMed  PubMed Central  Google Scholar 

Grassi G, D’Arrigo G, Pisano A, Bolignano D, Mallamaci F, Dell’Oro R, et al. Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis. J Hypertens. 2019;37:1746–56.

Article  CAS  PubMed  Google Scholar 

Biffi A, Quarti-Trevano F, Bonzani M, Seravalle G, Corrao G, Mancia G, et al. Neuroadrenergic activation in obstructive sleep apnoea syndrome A new selected meta-analysis revisited. J Hypertens. 2022;40:15–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grassi G, Biffi A, Dell’Oro R, Quarti Trevano F, Seravalle G, Corrao G, et al. Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis. J Hypertens. 2020;38:1436–42.

Article  CAS  PubMed  Google Scholar 

Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.

Article  Google Scholar 

Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.

Article  Google Scholar 

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta- analyses. BMJ. 2003;327:557–60.

Article  PubMed  PubMed Central  Google Scholar 

Higgins J, Green S. Cochrane handbook for systematic reviews of Interventions version 5.1.0. The Cochrane Collaboration. 2011. http://handbook-5-1.cochrane.org. Accessed October 9 2023.

Lohmeier TE, Iliescu R, Dwyer TM, Irwin ED, Cates AW, Rossing MA. Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex. Am J Physiol. 2010;299:H402–H9.

CAS  Google Scholar 

Laragh JH, Sealey JE. The plasma renin test reveals the contribution of body sodium- volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Am J Hypertens. 2011;24:1164–80.

Article  CAS  PubMed  Google Scholar 

Grassi G, Dell’Oro R, Bombelli M, Cuspidi C, Quarti-Trevano F. High blood pressure with elevated heart rate: a high risk ”sympathetic” clinical phenotype. Hypertens Res. 2023;46:2318–25.

Article  PubMed  Google Scholar 

Gronda E, Seravalle G, Brambilla G, Costantino G, Casini A, Trevano FQ, et al. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function and cardiac haemodynamics in heart failure: a proof-of-concept study. Eur J Heart Fail. 2014;16:977–83.

Article  PubMed  Google Scholar